Business Context and Reporting Period
This Form 8-K is filed by Creative Realities, Inc. (CREX) on November 19, 2025, reporting events related to a financing transaction completed on November 6, 2025, and subsequent changes to the Board of Directors.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on corporate governance and financing structure rather than operational financial performance.
Material Changes
- Financing Transaction: On November 6, 2025, the Company completed the "North Run Financing," issuing Series A Convertible Preferred Stock to North Run Strategic Opportunities Fund I, LP and NR-SOF I (Co-Invest I), LP.
- Board Composition: The Board size was initially increased to seven directors, including two designees from the Lead Investor (Thomas B. Ellis and Michael P. Bosco).
- Regulatory Compliance Action: Nasdaq determined that the Lead Investor's right to appoint directors representing 20% or more of the Board constituted a "change of control" under Nasdaq Rule 5635(b).
- Director Resignation: To maintain Nasdaq compliance, Michael P. Bosco resigned as a director effective November 19, 2025. The Board size was reduced to six directors.
Outlook, Risks, and Contingencies
- Shareholder Approval Requirement: The Buyers have agreed not to exercise their right to designate a second director until shareholders approve the "change of control."
- Upcoming Meeting: The Company intends to hold its 2025 annual meeting of shareholders on December 29, 2025, to seek this approval.
- Contingent Re-appointment: If shareholder approval is granted, the Board will be increased back to seven directors, and Mr. Bosco will be re-appointed.
Investor Verification Checklist
- Verify the terms of the Series A Convertible Preferred Stock issued in the North Run Financing.
- Confirm the outcome of the shareholder vote scheduled for December 29, 2025, regarding the change of control.
- Monitor the final composition of the Board of Directors following the shareholder meeting.
- Review the impact of the financing on the Company's capital structure and dilution.